MAPT Human 381a.a.

Microtubule-Associated Protein Tau 381 a.a. Human Recombinant
Cat. No.
BT13050
Source
Escherichia Coli.
Synonyms
Microtubule-associated protein tau, isoform CRA_f, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau, MAPT, MAPTL, MTBT1, TAU, MSTD, PPND, DDPAC, MTBT2, FTDP-17, FLJ31424, MGC138549.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 85.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

MAPT Human Recombinant fused with a 20 amino acid His tag at N-terminus produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 401 amino acids (1-381 a.a.) and having a molecular mass of 41.8kDa. The NCBI Accession No. is EAW93573.1.
The MAPT is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Microtubule-associated protein tau (MAPT or Tau) is a protein that helps stabilize microtubules, which are important for cell structure and function. It is primarily found in neurons of the central nervous system. When MAPT is defective and cannot stabilize microtubules correctly, it can lead to neurodegenerative disorders like Alzheimer's disease.
Description
This product is a recombinant human MAPT protein consisting of 401 amino acids (including a 20 amino acid His tag at the N-terminus). It is produced in E. coli and has a molecular weight of 41.8 kDa. This protein is not glycosylated and corresponds to amino acids 1-381 of the human MAPT protein (NCBI Accession No. EAW93573.1). The protein is purified using proprietary chromatographic methods to ensure high purity.
Physical Appearance
Clear, colorless, and sterile filtered solution.
Formulation
The MAPT protein is supplied in a solution containing 0.5 mg/ml MAPT, 20mM Tris-HCl buffer (pH 7.5), 1mM DTT, and 20% glycerol.
Stability
For short-term storage (up to 2-4 weeks), keep the vial at 4°C. For long-term storage, freeze the product at -20°C. Adding a carrier protein such as 0.1% HSA or BSA is recommended for long-term storage. Avoid repeatedly freezing and thawing the product.
Purity
The purity of this product is greater than 85%, as determined by SDS-PAGE analysis.
Synonyms
Microtubule-associated protein tau, isoform CRA_f, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau, MAPT, MAPTL, MTBT1, TAU, MSTD, PPND, DDPAC, MTBT2, FTDP-17, FLJ31424, MGC138549.
Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MAEPRQEFEV MEDHAGTYGL GDRKDQGGYT MHQDQEGDTD AGLKESPLQT PTEDGSEEPG SETSDAKSTP TAEAEEAGIG DTPSLEDEAA GHVTQARMVS KSKDGTGSDD KKAKGADGKT KIATPRGAAP PGQKGQANAT RIPAKTPPAP KTPPSSGEPP KSGDRSGYSS PGSPGTPGSR SRTPSLPTPP TREPKKVAVV RTPPKSPSSA KSRLQTAPVP MPDLKNVKSK IGSTENLKHQ PGGGKVQIVY
KPVDLSKVTS KCGSLGNIHH KPGGGQVEVK SEKLDFKDRV QSKIGSLDNI THVPGGGNKK IETHKLTFRE NAKAKTDHGA EIVYKSPVVS GDTSPRHLSN VSSTGSIDMV DSPQLATLAD EVSASLAKQG L.

Product Science Overview

Introduction

Microtubule-Associated Protein Tau (MAPT), commonly referred to as Tau, is a protein that plays a crucial role in stabilizing microtubules in neurons. The specific variant, Tau 381 a.a. (Human Recombinant), is a recombinant form of this protein, consisting of 381 amino acids. This article delves into the structure, function, and significance of this protein, particularly in the context of neurodegenerative diseases.

Structure and Isoforms

Tau proteins are encoded by the MAPT gene, which undergoes alternative splicing to produce six isoforms in the human brain. These isoforms vary in the number of microtubule-binding repeats and N-terminal inserts. Tau 381 a.a. is one of these isoforms, characterized by having three microtubule-binding repeats (3R) and one N-terminal insert (1N) .

Function

The primary function of Tau is to stabilize microtubules, which are essential components of the cytoskeleton. Microtubules provide structural support and facilitate intracellular transport. Tau achieves this by binding to microtubules and promoting their assembly and stability . In its recombinant form, Tau 381 a.a. retains these functional properties, making it a valuable tool for research.

Role in Neurodegenerative Diseases

Tau is predominantly found in neurons of the central nervous system. When Tau proteins become hyperphosphorylated, they lose their ability to bind to microtubules effectively. This leads to the formation of neurofibrillary tangles, a hallmark of Alzheimer’s disease and other tauopathies . The accumulation of these tangles disrupts neuronal function and contributes to neurodegeneration.

Recombinant Tau 381 a.a.

Recombinant Tau 381 a.a. is produced using Escherichia coli (E. coli) expression systems. This recombinant protein is often used in research to study the biochemical properties of Tau, its interactions with other proteins, and its role in disease pathology . The recombinant form is typically purified to high levels of purity, ensuring its suitability for various experimental applications.

Applications in Research

Recombinant Tau 381 a.a. is widely used in studies related to:

  • Microtubule Dynamics: Understanding how Tau stabilizes microtubules and the effects of its dysfunction.
  • Protein Interactions: Investigating how Tau interacts with other proteins and its role in cellular processes.
  • Disease Mechanisms: Exploring the mechanisms underlying tauopathies and developing potential therapeutic interventions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.